Evaluating tuberculosis control programs: Strategies, tools and models

International Journal of Tuberculosis and Lung Disease

Volumn 4, Issue 2 SUPPL. 1, 2000, Pages

  Chaulk, C P ^a,b,c   Grady, M ^a  

^a Annie E Casey Foundation   (United States)

^b Baltimore City Chest Clinic   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASE STUDY; CLINICAL RESEARCH; COMMUNITY CARE; CONFERENCE PAPER; ECONOMICS; EVALUATION; HEALTH CARE QUALITY; HEALTH PROGRAM; METHODOLOGY; MODEL; OUTCOMES RESEARCH; PRIORITY JOURNAL; TUBERCULOSIS CONTROL;

COMMUNITY HEALTH SERVICES; HUMANS; INFECTION CONTROL; MODELS, ECONOMIC; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT COMPLIANCE; PROGRAM EVALUATION; TUBERCULOSIS, PULMONARY;

EID: 0034087671     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (14)

1. Centers for Disease Control and Prevention. Initial therapy for tuberculosis in the era of multi-drug resistance: recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep. 1993; 42: 1-8.
2. Centers for Disease Control and Prevention. Tuberculosis Program Management in the United States 1986-1991. Atlanta, GA: Centers for Disease Control and Prevention; 1993.
3. Bloch A B, Simone P M, Leary L S, Hayden C H, Seggerson J J, Castro K G. Completion of tuberculosis therapy for patients reported in the United States in 1993. Int J Tuberc Lung Dis 1999; 3: 273-280.
4. Centers for Disease Control and Prevention. Improving patient adherence to tuberculosis treatment. Revised ed. Atlanta, GA: Centers for Disease Control and Prevention, US Dept of Health and human Services, Public Health Service; 1994.
5. Centers for Disease Control and Prevention. Initial therapy for tuberculosis in the era of multi-drug resistance: recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep 1993; 42: 1-8.
6. American Thoracic Society, Medical Section of the American Lung Association. Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med 1994; 149: 1359-1374.
7. Stake R E. Case studies in clinical research. In: N. K. Denzin, Y S Lincoln, eds. Handbook of qualitative research. Thousand Oaks, CA: Sage Publications, 1994: 236-248.
8. Chaulk C P, Chaisson R E, Lewis J N, Rizzo R T. Treating multidrug resistant tuberculosis: compliance and side effects. JAMA 1994; 271: 103-104.
9. Chaulk C P, Moore Rice K, Rizzo R, Chaisson R E. Eleven years of community-based directly observed therapy for tuberculosis. JAMA 1995; 274: 945-951.
10. Chaulk C P, Pope D S. The Baltimore City Health Department program of directly observed therapy for tuberculosis. Clin Chest Med 1997; 18: 149-154.
11. Alwood K, Keruly J, Moore-Rice K, Stanton D L, Chaulk C P, Chaisson R E. Effectiveness of supervised, intermittent therapy for tuberculosis in HIV-infected patients. AIDS 1994; 8: 1103-1108.
12. Miller W L, Crabtree B F, Clinical research. In: N. K. Denzin, Y. S. Lincoln, eds. Handbook of qualitative research. Thousand Oaks, CA: Sage Publications 1994: 340-352.
13. Chaulk C P, Kazandjian V A. Directly observed therapy for treatment completion of pulmonary tuberculosis. JAMA 1998; 279: 943-948.
14. Moore R D, Chaulk C P, Griffiths R, Cavalconte S, Chaisson R E. Cost effectiveness of directly observed versus self-administered therapy for tuberculosis. Am J Respir Crit Care Med 1996; 154: 1013-1019